Market Cap: $603.07M
MI
Myriad Genetics, Inc.
MYGN
NASDAQUSD
Market Cap: $603.07M
Innovative Advances in Genetic Testing Propel Myriad Genetics Forward Myriad Genetics, a leader in the field of molecular diagnostics and personalized medicine, continues to make significant strides i…
Myriad Genetics Expands Genetic Testing Offerings in Precision Medicine Myriad Genetics is making significant strides in the field of precision medicine, demonstrating its commitment to evolving and e…
NEW YORK, Feb 23 (Reuters) - Myriad Genetics is scheduled to report quarterly results on Monday, and the company's diagnostic operations take center stage as management prepares to detail recent trend…
Myriad Genetics Focuses on Advancements in Genetic Testing Amid Earnings Season In the evolving landscape of genetic testing, Myriad Genetics remains at the forefront of innovation. As the company nav…
Myriad Genetics Focuses on Innovation Amid Industry Earnings Reports In a landscape marked by fluctuating economic conditions, Myriad Genetics emphasizes the importance of innovation in genetic testin…
Myriad Genetics Prepares for Key Earnings Report Amid Innovation and Market Expansion As Myriad Genetics approaches the release of its quarterly earnings report on November 3, 2025, the focus is squar…
Myriad Genetics Gears Up for Strategic Earnings Report Amid Market Anticipation As Myriad Genetics approaches its quarterly earnings report set for November 3, 2025, the biotechnology company remains…
Myriad Genetics Strengthens Investment Strategy with Key Appointment Myriad Genetics takes a significant step in enhancing its investment strategy with the appointment of Sarah Adams as Partner & Head…
Myriad Genetics Enhances Strategic Vision with New Leadership Appointment Myriad Genetics strengthens its position in the venture capital landscape with the recent appointment of Sarah Adams as Partne…
Myriad Genetics Expands Strategic Capabilities with New Partner Appointment Myriad Genetics, through its early-stage venture firm Myriad Venture Partners, strengthens its leadership team by appointing…
Myriad Genetics and SOPHiA GENETICS Team Up for Liquid Biopsy Companion Diagnostics Myriad Genetics, a prominent player in molecular diagnostic testing, solidifies its position in the oncology landsca…
Myriad Genetics and SOPHiA GENETICS Unite for Liquid Biopsy Companion Diagnostic Development Myriad Genetics, a prominent player in molecular diagnostic testing, announces a strategic collaboration wi…
Myriad Genetics and SOPHiA GENETICS Forge Strategic Alliance for Liquid Biopsy Companion Diagnostics Myriad Genetics, a prominent player in molecular diagnostic testing, has initiated a strategic coll…
Transformative Shift in Online Betting: Blockchain's Emergence In a significant development within the online betting industry, a former executive from Polymarket has announced a $15 million investmen…
Blockchain's Emergence in Online Betting: A New Frontier for Myriad Genetics In the rapidly evolving landscape of online betting, the adoption of blockchain technology signifies a transformative shift…
Myriad Genetics Advances in Precision Medicine Amid Market Optimism In the evolving landscape of precision medicine, Myriad Genetics continues to position itself as a leader in genetic testing and per…
Myriad Genetics Sees Surge in Growth Potential Following Strong Earnings Report Myriad Genetics Inc. showcases its robust market positioning and strategic initiatives with a second-quarter earnings re…
Myriad Genetics Sets a New Course with Strong Q2 Results Myriad Genetics Inc. announces a remarkable second-quarter performance that significantly exceeds analysts' expectations, showcasing the compan…
Myriad Genetics' Robust Earnings Signal Future Growth in Precision Medicine Myriad Genetics Inc. demonstrates impressive momentum following the release of its second-quarter financial results, which e…
Myriad Genetics Enhances Genetic Testing Portfolio Amid Market Volatility In a rapidly changing healthcare landscape, Myriad Genetics focuses on expanding its genetic testing services to cater to the…
Myriad Genetics Navigates Evolving Landscape in Genetic Testing Myriad Genetics, a leader in molecular diagnostics, continues to adapt to shifts in the healthcare landscape, particularly as advancemen…
Myriad Genetics: Leadership Transition Sparks Optimism for Business Growth In recent trading, Myriad Genetics experiences a notable uptick, with its shares rising by 7% following an upgrade to an "ove…
Myriad Genetics Gains Momentum with Upgraded Ratings and Positive Outlook Myriad Genetics, a leader in molecular diagnostics and personalized medicine, experiences a notable uptick in its stock price…
Myriad Genetics Positioned for Growth Following Upgrade Myriad Genetics, a leader in precision medicine, experiences a notable boost as Piper Sandler upgrades the company to an “overweight” rating, ra…
Oncology NGS Market Poised for Significant Growth Amid Rising Cancer Incidence The global oncology next-generation sequencing (NGS) market is on a promising growth trajectory, valued at approximately…